ASX
LCT 0.105   Last updated 7.14 am
Fact sheet
The following fact sheets provide a summary of our current business and research pipeline.
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.

Fact sheet

The following fact sheet provides a summary of our current business and research pipeline.

Diatranz Otsuka Limited

Living Cell Technologies formed a partnership with Otsuka Pharmaceutical Factory, Inc. (Otsuka) in 2011 establishing the 50:50 New Zealand joint venture company Diatranz Otsuka Limited (DOL). DOL is a private company incorporated in New Zealand. 

PRINT PAGE
Register for email updates
Register now to receive our newsletter and updates on LCT’s activities and progress.